Home › Funds › Avidity Partners Management LP › GMAB
Avidity Partners Management LP position in GMAB
GENMAB A/S · Health Care
Avidity Partners Management LP reported holding 50,000 shares of GMAB (GENMAB A/S) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 0.22% of its reported portfolio and ranking #33 among its reported holdings. Avidity Partners Management LP has disclosed GMAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Avidity Partners Management LP's GMAB position evolved
Avidity Partners Management LP first disclosed a stake in GMAB in Q1 2025 at 433,100 shares (US$8.5M). The position peaked in Q2 2025 at 650,000 shares, worth US$13.4M. Across 6 filings, Avidity Partners Management LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 50,000 shares valued at US$1.4M. Notable position changes include a 50% increase in Q2 2025 (shares rose 48% over the following quarter), a 62% trim in Q3 2025 (shares were roughly flat over the following quarter), a 63% trim in Q4 2025 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 433.10K | $8.48M | New |
| Q2 2025 | 650.00K | $13.43M | Add |
| Q3 2025 | 248.10K | $7.61M | Reduce |
| Q4 2025 | 92.00K | $2.83M | Reduce |
| Q1 2026 | 50.00K | $1.34M | Reduce |
| Q2 2026 | 50.00K | $1.37M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 31 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
- Deep Track Capital, LP 3.00M sh · $82.41M · Q2 2026
More on Avidity Partners Management LP
FAQ
How long has Avidity Partners Management LP held GMAB?
Avidity Partners Management LP has disclosed GMAB holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Avidity Partners Management LP's current position in GMAB?
As of Q2 2026, Avidity Partners Management LP holds 50.00K shares of GMAB (GENMAB A/S), valued at $1.37M, representing 0.22% of its reported portfolio and ranking #33.
Has Avidity Partners Management LP been buying or selling GMAB?
In the latest 13F filing (Q2 2026), Avidity Partners Management LP held unchanged its position in GMAB. The position peaked in Q2 2025 at 650.00K shares.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.